Updated:
Lupin Limited
Lupin Limited, led by CEO Vinita D. Gupta, produces over 2,500 generic drug formulations across 70+ markets, making it a top-five Indian pharma firm.
Lupin Limited
Lupin Limited was founded in 1968 by Dr. Desh Bandhu Gupta in Mumbai, India. Vinita D. Gupta serves as CEO, while Nilesh D. Gupta holds the role of Managing Director. The company's wealth originates from its pharmaceutical operations, with no public disclosure of a family office structure. Lupin's strategy centers on generic pharmaceuticals, with a focus on complex generics, biosimilars, and active pharmaceutical ingredients (APIs). It covers therapeutic areas including cardiovascular, central nervous system, respiratory, and anti-infective treatments. Lupin's branded portfolio includes drugs for asthma, diabetes, and hypertension. The firm has a presence in over 70 markets, including the United States, India, and Japan. The company employs over 15,000 professionals, with manufacturing sites in India and the United States. Lupin has a research and development facility in Pune, India. In 2023, Lupin launched a biosimilar of a major diabetes drug in the Indian market (per industry reports, 2023). It also has a philanthropic arm, the Lupin Foundation, which focuses on healthcare, education, and community development. A structural differentiator is Lupin's vertically integrated model, covering R&D, manufacturing, and distribution of both generic and branded pharmaceuticals. This contrasts with pure-play generic firms that often outsource production or R&D, giving Lupin control over its supply chain and quality standards.
General information
Firm type
Asset Manager
Year founded
1968
AUM
Undisclosed
Location
Region
Asia
Country
India
City
Mumbai
Corporate office
Mumbai, Maharashtra, India
Principals
Vinita D. Gupta
CEO
Nilesh D. Gupta
Managing Director
Sector focus
Frequently asked questions
Who runs investment decisions at Lupin Limited?
Lupin is a publicly traded pharmaceutical company, not a family office. Investment decisions are made by its board of directors and executive management, including CEO Vinita D. Gupta and Managing Director Nilesh D. Gupta.
How does Lupin source proprietary deal flow?
Lupin does not operate as an investment firm. Its deal flow comes from in-house R&D, licensing agreements, and acquisitions of drug portfolios or companies in its therapeutic areas of focus.
Is Lupin structured as a single family office or does it operate more like a venture firm?
Lupin is a publicly listed pharmaceutical company, not a family office or venture firm. It is governed by a board of directors and reports financial results to stock exchanges and regulators.
Does Lupin participate in fund commitments or only direct deals?
Lupin primarily engages in direct pharmaceutical manufacturing and R&D. It does not participate in fund commitments as an LP. Any investments are typically in tangible assets like manufacturing facilities or intellectual property.
What investment stages does Lupin typically target?
Lupin focuses on development-stage and commercial-stage generic drugs, biosimilars, and APIs. It does not invest in early-stage startups or venture capital.
Which sectors does Lupin explicitly avoid?
Lupin does not publicly disclose excluded sectors. Its operations are concentrated in pharmaceuticals, with no known activity in financial services, technology, or other non-pharma areas.
How is Lupin related to a family office?
Lupin is a publicly traded company with a founding family, the Gupta family, but no separate family office has been publicly identified. The family's wealth is managed through the corporate structure and personal investments, not a disclosed single-family office.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: